153 related articles for article (PubMed ID: 12125243)
1. [Adverse effects of multi-drug therapy in patients with tuberculosis and ways of their correction].
Gel'berg IS; Vol'f SB; Vrublevskaia NI; Pigalkova EN; Krotkova EN; Shevchuk DV; Avlasenko VS
Probl Tuberk; 2002; (4):12-6. PubMed ID: 12125243
[TBL] [Abstract][Full Text] [Related]
2. [Current aspects of pathogenetic therapy in tuberculosis].
Balasaniants GS; Sukhanov DS
Ter Arkh; 2011; 83(8):21-4. PubMed ID: 21961327
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenetic therapy of pulmonary tuberculosis in adolescents].
Pavlova MV
Probl Tuberk; 1994; (3):19-21. PubMed ID: 7937663
[TBL] [Abstract][Full Text] [Related]
4. [Effect of antioxidants on lipid peroxidation and on liver function in patients with pulmonary tuberculosis].
Skakun NL; Blikhar EI
Farmakol Toksikol; 1986; 49(5):112-4. PubMed ID: 3770163
[TBL] [Abstract][Full Text] [Related]
5. [Antioxidant treatment of pulmonary tuberculosis in patients with chronic alcoholism].
Burnusus ZI
Probl Tuberk; 1992; (5-6):28-30. PubMed ID: 1409509
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of destructive pulmonary tuberculosis with antioxidants and antihypoxic agents].
Savula MM; Kravchenko NS; Poznanskiĭ AI
Probl Tuberk; 1993; (5):18-20. PubMed ID: 8295877
[TBL] [Abstract][Full Text] [Related]
7. [Antioxidant effectiveness in preventing and eliminating the side effects of antibacterial preparations in pulmonary tuberculosis patients].
Starostenko EV; Andrzheiuk NI; Salpagarov AM
Probl Tuberk; 1987; (10):34-7. PubMed ID: 3422950
[No Abstract] [Full Text] [Related]
8. [Pathogenetic therapy in pulmonary tuberculosis].
Starostenko EV
Probl Tuberk; 1989; (5):22-6. PubMed ID: 2748555
[TBL] [Abstract][Full Text] [Related]
9. [Adverse reactions of antituberculous agents, especially about its onset and duration].
Yamada H; Yasuoka A; Sasayama K; Doutsu Y; Hayashi T; Kohno S; Yamaguchi K; Hirota M; Hara K
Kekkaku; 1990 Sep; 65(9):563-8. PubMed ID: 2232434
[TBL] [Abstract][Full Text] [Related]
10. [The efficacy of antioxidant therapy in patients with tuberculosis of the lungs and the correction of lipid peroxidation processes].
Safarian MD; Karagezian KG; Karapetian ET; Avanesian NA
Probl Tuberk; 1990; (5):40-4. PubMed ID: 2388892
[TBL] [Abstract][Full Text] [Related]
11. [Antioxidants--effective pathogenetic agents in the combined therapy of pulmonary tuberculosis].
Gur'eva IG; Starostenko EV; Narovlianskaia SE
Ter Arkh; 1987; 59(7):72-4. PubMed ID: 3672365
[TBL] [Abstract][Full Text] [Related]
12. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
14. [Individual approaches to complex treatment of disseminated tuberculous processes in adolescents].
Gergert VIa; Rusakova LI
Probl Tuberk Bolezn Legk; 2006; (8):33-7. PubMed ID: 17002056
[TBL] [Abstract][Full Text] [Related]
15. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
Khodashova ML; Iuditskiĭ MV; Semenova OV
Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
[TBL] [Abstract][Full Text] [Related]
16. [Efficiency treatment of new cases of destructive pulmonary tuberculosis in the presence of concurrent iron deficiency anemia].
Voloshina VV; Fomicheva NI
Probl Tuberk; 2002; (2):10-2. PubMed ID: 11899794
[TBL] [Abstract][Full Text] [Related]
17. [Complex treatment of destructive pulmonary tuberculosis].
Shul'ga IA; Znosenko VA; Sukhorukova IS; Davydova GN; Surovtseva EIa; Shlapakova MA; Pelipas IG
Probl Tuberk Bolezn Legk; 2003; (7):29-31. PubMed ID: 12939873
[TBL] [Abstract][Full Text] [Related]
18. [Frequency and pattern of adverse reactions due to treatment of patients with pulmonary tuberculosis with antitubercular reserve drugs].
Chukanov VI; Kaminskaia GO; Livchane E
Probl Tuberk Bolezn Legk; 2004; (10):6-10. PubMed ID: 15568310
[TBL] [Abstract][Full Text] [Related]
19. [Changes in the patients' mental status in the tolerability of antituberculous drugs].
Mordyk AV; Briukhanova NS; Kazakov AV
Probl Tuberk Bolezn Legk; 2009; (3):38-42. PubMed ID: 19455986
[TBL] [Abstract][Full Text] [Related]
20. [Correction of bronchial obstructive syndrome and antituberculous drugs-induced eosinophilia in patients with pulmonary tuberculosis by using plasmapheresis].
Shmelev EI; Stepanian IE
Probl Tuberk; 1996; (6):57-60. PubMed ID: 9019774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
